• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

钆塞酸二钠增强肝脏磁共振成像:第 2 部分,方案优化和肝硬化肝脏中的病变表现。

Gadoxetate disodium-enhanced MRI of the liver: part 2, protocol optimization and lesion appearance in the cirrhotic liver.

机构信息

Department of Radiology, University of California, San Diego, 92103, USA.

出版信息

AJR Am J Roentgenol. 2010 Jul;195(1):29-41. doi: 10.2214/AJR.10.4538.

DOI:10.2214/AJR.10.4538
PMID:20566795
Abstract

OBJECTIVE

The purpose of this article is to review the use of gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid (gadoxetate disodium [Gd-EOB-DTPA]) in the cirrhotic liver and illustrate the imaging appearance of lesions commonly encountered in the cirrhotic liver.

CONCLUSION

Gd-EOB-DTPA shows promise as a problem-solving tool in the cirrhotic liver because it provides additional information that may be helpful in lesion detection and characterization. Further research is needed to optimize Gd-EOB-DTPA imaging protocols in cirrhosis and develop diagnostic criteria for liver lesions in the cirrhotic liver.

摘要

目的

本文旨在回顾钆塞酸二钠(gadoxetate disodium [Gd-EOB-DTPA])在肝硬化肝脏中的应用,并举例说明肝硬化肝脏中常见病变的影像学表现。

结论

Gd-EOB-DTPA 有望成为肝硬化肝脏的一种解决问题的工具,因为它提供了可能有助于病变检测和特征描述的额外信息。需要进一步研究来优化肝硬化中的 Gd-EOB-DTPA 成像方案,并为肝硬化肝脏中的肝脏病变制定诊断标准。

相似文献

1
Gadoxetate disodium-enhanced MRI of the liver: part 2, protocol optimization and lesion appearance in the cirrhotic liver.钆塞酸二钠增强肝脏磁共振成像:第 2 部分,方案优化和肝硬化肝脏中的病变表现。
AJR Am J Roentgenol. 2010 Jul;195(1):29-41. doi: 10.2214/AJR.10.4538.
2
Gadoxetate disodium-enhanced MRI of the liver: part 1, protocol optimization and lesion appearance in the noncirrhotic liver.钆塞酸二钠增强肝脏 MRI:第 1 部分,方案优化和非肝硬化肝脏病变表现。
AJR Am J Roentgenol. 2010 Jul;195(1):13-28. doi: 10.2214/AJR.10.4392.
3
Gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging predicts the histological grade of hepatocellular carcinoma only in patients with Child-Pugh class A cirrhosis.钆喷替酸葡甲胺增强磁共振成像仅能预测 Child-Pugh 分级为 A 级肝硬化患者的肝癌组织学分级。
Liver Transpl. 2012 Jul;18(7):850-7. doi: 10.1002/lt.23426.
4
Gd-EOB-DTPA enhanced MR imaging: evaluation of biliary and renal excretion in normal and cirrhotic livers.钆塞酸二钠增强磁共振成像:正常和肝硬化肝脏的胆道和肾脏排泄评估。
Eur J Radiol. 2011 Dec;80(3):e207-11. doi: 10.1016/j.ejrad.2010.08.033. Epub 2010 Sep 24.
5
Qualitative and quantitative evaluation of hepatocellular carcinoma and cirrhotic liver enhancement using Gd-EOB-DTPA.使用钆塞酸二钠对肝细胞癌和肝硬化肝脏增强的定性和定量评估
AJR Am J Roentgenol. 2009 Oct;193(4):1053-60. doi: 10.2214/AJR.08.1946.
6
Evaluation of gadoxetate disodium as a contrast agent for mouse liver imaging: comparison with gadobenate dimeglumine.钆塞酸二钠作为小鼠肝脏成像造影剂的评估:与钆贝葡胺的比较。
Magn Reson Imaging. 2009 Jan;27(1):101-7. doi: 10.1016/j.mri.2008.05.015. Epub 2008 Jul 3.
7
Dynamic-contrast-enhanced magnetic resonance imaging of cirrhotic liver parenchyma: A comparison between gadolinium-diethylenetriamine pentaacetic acid and gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid.肝硬化肝实质的动态对比增强磁共振成像:钆喷酸葡胺与钆贝葡胺的比较
J Chin Med Assoc. 2015 Nov;78(11):666-72. doi: 10.1016/j.jcma.2015.07.005. Epub 2015 Sep 2.
8
New proposal for the staging of nonalcoholic steatohepatitis: evaluation of liver fibrosis on Gd-EOB-DTPA-enhanced MRI.非酒精性脂肪性肝炎分期的新建议:钆塞酸二钠增强 MRI 评估肝纤维化。
Eur J Radiol. 2010 Jan;73(1):137-42. doi: 10.1016/j.ejrad.2008.09.036. Epub 2008 Nov 20.
9
Dilution method of gadolinium ethoxybenzyl diethylenetriaminepentaacetic acid (Gd-EOB-DTPA)-enhanced magnetic resonance imaging (MRI).钆乙氧基苄基二乙三胺五乙酸(Gd-EOB-DTPA)增强磁共振成像(MRI)的稀释方法。
J Magn Reson Imaging. 2009 Oct;30(4):849-54. doi: 10.1002/jmri.21913.
10
A case of Budd-Chiari syndrome: Gd-EOB-DTPA-enhanced MR findings.布-加综合征 1 例:钆塞酸二钠增强磁共振成像表现。
Magn Reson Imaging. 2011 May;29(4):579-83. doi: 10.1016/j.mri.2010.10.013. Epub 2011 Jan 8.

引用本文的文献

1
Value of enhancing capsule for diagnosing hepatocellular carcinoma on MRI: implications for simplifying LI-RADS.MRI增强扫描对肝细胞癌的诊断价值:对简化肝脏影像报告和数据系统(LI-RADS)的启示
Eur Radiol. 2025 Aug 22. doi: 10.1007/s00330-025-11938-x.
2
LI-RADS v2018 category and imaging features: inter-modality agreement between contrast-enhanced CT, gadoxetate disodium-enhanced MRI, and extracellular contrast-enhanced MRI.LI-RADS v2018 分类和影像学特征:对比增强 CT、钆塞酸二钠增强 MRI 和细胞外对比增强 MRI 之间的多模态一致性。
Radiol Med. 2024 Nov;129(11):1575-1586. doi: 10.1007/s11547-024-01879-8. Epub 2024 Aug 19.
3
A convenient and reproducible protocol for acquisition of the hepatocyte phase for liver function-impaired patients in gadoxetic acid disodium-enhanced magnetic resonance imaging.
一种用于在钆塞酸二钠增强磁共振成像中获取肝功能受损患者肝细胞期图像的简便且可重复的方案。
Quant Imaging Med Surg. 2024 Feb 1;14(2):1904-1915. doi: 10.21037/qims-23-1147. Epub 2024 Jan 18.
4
Hepatobiliary phase imaging in cirrhotic patients using compressed sensing and controlled aliasing in parallel imaging results in higher acceleration.使用压缩感知和并行成像中的控制混叠在肝硬化患者的肝胆期成像中实现更高的加速。
Eur Radiol. 2024 Apr;34(4):2233-2243. doi: 10.1007/s00330-023-10226-w. Epub 2023 Sep 21.
5
Optimization of hepatobiliary phase imaging in gadoxetic acid-enhanced magnetic resonance imaging: a narrative review.钆塞酸二钠增强磁共振成像中肝胆期成像的优化:一篇叙述性综述
Quant Imaging Med Surg. 2023 Mar 1;13(3):1972-1982. doi: 10.21037/qims-22-916. Epub 2023 Feb 10.
6
Diagnostic Performance of Simulated Abbreviated MRI for Early-Stage Hepatocellular Carcinoma Screening: A Comparison to Conventional Dynamic Contrast-Enhanced MRI.用于早期肝细胞癌筛查的模拟简化磁共振成像的诊断性能:与传统动态对比增强磁共振成像的比较
Taehan Yongsang Uihakhoe Chi. 2021 Sep;82(5):1218-1230. doi: 10.3348/jksr.2020.0172. Epub 2021 Sep 27.
7
Total Bilirubin Level as a Predictor of Suboptimal Image Quality of the Hepatobiliary Phase of Gadoxetic Acid-Enhanced MRI in Patients with Extrahepatic Bile Duct Cancer.总胆红素水平可预测胆外胆管癌患者行钆塞酸增强 MRI 肝胆期时图像质量不佳。
Korean J Radiol. 2022 Apr;23(4):389-401. doi: 10.3348/kjr.2021.0407. Epub 2022 Jan 4.
8
Hepatobiliary phase signal intensity: A potential method of diagnosing HCC with atypical imaging features among LR-M observations.肝胆期信号强度:LR-M 观察中具有非典型影像学特征的 HCC 诊断的一种潜在方法。
PLoS One. 2021 Sep 13;16(9):e0257308. doi: 10.1371/journal.pone.0257308. eCollection 2021.
9
Evaluation of liver function in patients with chronic hepatitis B using Gd-EOB-DTPA-enhanced T1 mapping at different acquisition time points: a feasibility study.使用不同采集时间点的钆塞酸二钠增强 T1 mapping 评估慢性乙型肝炎患者的肝功能:一项可行性研究。
Radiol Med. 2021 Sep;126(9):1149-1158. doi: 10.1007/s11547-021-01382-4. Epub 2021 Jun 8.
10
Assessing locoregional treatment response to Hepatocellular Carcinoma: comparison of hepatobiliary contrast agents to extracellular contrast agents.评估肝细胞癌的局部区域治疗反应:肝胆对比剂与细胞外对比剂的比较。
Abdom Radiol (NY). 2021 Aug;46(8):3565-3578. doi: 10.1007/s00261-021-03076-x. Epub 2021 Apr 15.